{"id":"https://openalex.org/W4239255504","doi":"https://doi.org/10.1111/epi.14532","title":"Further evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein","display_name":"Further evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein","alternate_titles":[],"publication_year":2018,"publication_date":"2018-08-24","ids":{"openalex":"https://openalex.org/W4239255504","doi":"https://doi.org/10.1111/epi.14532"},"language":"en","primary_location":{"id":"doi:10.1111/epi.14532","doi":"https://doi.org/10.1111/epi.14532","is_oa":false,"landing_page_url":"https://doi.org/10.1111/epi.14532","pdf_url":null,"source":{"id":"https://openalex.org/S203153751","display_name":"Epilepsia","issn_l":"0013-9580","issn":["0013-9580","1528-1157","1528-1167"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4239255504"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103815893","display_name":"Martyn D. Wood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I85722119","display_name":"UCB Pharma (Belgium)","ror":"https://ror.org/01n029866","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Martyn D. Wood","raw_affiliation_strings":["UCB BioPharma SPRL, Braine-l'Alleud, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB BioPharma SPRL, Braine-l'Alleud, Belgium","institution_ids":["https://openalex.org/I85722119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025107478","display_name":"Zara A. Sands","orcid":"https://orcid.org/0000-0001-5830-6246","observed_orcids":["https://orcid.org/0000-0001-5830-6246"]},"institutions":[{"id":"https://openalex.org/I85722119","display_name":"UCB Pharma (Belgium)","ror":"https://ror.org/01n029866","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Zara A. Sands","raw_affiliation_strings":["UCB BioPharma SPRL, Braine-l'Alleud, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB BioPharma SPRL, Braine-l'Alleud, Belgium","institution_ids":["https://openalex.org/I85722119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015729970","display_name":"Catherine Vandenplas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I85722119","display_name":"UCB Pharma (Belgium)","ror":"https://ror.org/01n029866","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Catherine Vandenplas","raw_affiliation_strings":["UCB BioPharma SPRL, Braine-l'Alleud, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB BioPharma SPRL, Braine-l'Alleud, Belgium","institution_ids":["https://openalex.org/I85722119"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087482611","display_name":"Michel R. Gillard","orcid":"https://orcid.org/0000-0003-0403-2328","observed_orcids":["https://orcid.org/0000-0003-0403-2328"]},"institutions":[{"id":"https://openalex.org/I85722119","display_name":"UCB Pharma (Belgium)","ror":"https://ror.org/01n029866","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Michel Gillard","raw_affiliation_strings":["UCB BioPharma SPRL, Braine-l'Alleud, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB BioPharma SPRL, Braine-l'Alleud, Belgium","institution_ids":["https://openalex.org/I85722119"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103815893"],"corresponding_institution_ids":["https://openalex.org/I85722119"],"apc_list":{"value":4360,"currency":"USD","value_usd":4360},"apc_paid":null,"fwci":2.4045,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.88504505,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"59","issue":"9","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.6157000064849854,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.6157000064849854,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.3562000095844269,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brivaracetam","display_name":"brivaracetam","score":1.0},{"id":"https://openalex.org/keywords/levetiracetam","display_name":"levetiracetam","score":1.0},{"id":"https://openalex.org/keywords/synaptic-vesicle-glycoprotein-2a","display_name":"SV2A","score":0.8889999985694885},{"id":"https://openalex.org/keywords/allosteric-modulation","display_name":"allosteric modulation","score":0.781000018119812},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.8479999899864197},{"id":"https://openalex.org/keywords/racetams","display_name":"racetams","score":0.7540000081062317},{"id":"https://openalex.org/keywords/amino-acid-mutations","display_name":"amino acid mutations","score":0.652999997138977},{"id":"https://openalex.org/keywords/drug-binding-sites","display_name":"drug binding sites","score":0.7080000042915344},{"id":"https://openalex.org/keywords/seizure-protection","display_name":"seizure protection","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C2777332695","wikidata":"https://www.wikidata.org/wiki/Q417227","display_name":"Levetiracetam","level":3,"score":0.8551745414733887},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.747715950012207},{"id":"https://openalex.org/C148785051","wikidata":"https://www.wikidata.org/wiki/Q671136","display_name":"Synaptic vesicle","level":4,"score":0.5942176580429077},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.4718252122402191},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.4577118754386902},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.41646310687065125},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40544530749320984},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3828543722629547},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3012233376502991},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.29685527086257935},{"id":"https://openalex.org/C130316041","wikidata":"https://www.wikidata.org/wiki/Q189206","display_name":"Vesicle","level":3,"score":0.262845903635025},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.17819559574127197},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1424189805984497},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11608794331550598},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1111/epi.14532","doi":"https://doi.org/10.1111/epi.14532","is_oa":false,"landing_page_url":"https://doi.org/10.1111/epi.14532","pdf_url":null,"source":{"id":"https://openalex.org/S203153751","display_name":"Epilepsia","issn_l":"0013-9580","issn":["0013-9580","1528-1157","1528-1167"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8560000061988831,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337846","display_name":"UCB Pharma","ror":"https://ror.org/01n029866"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1505043869","https://openalex.org/W1986742054","https://openalex.org/W1990562318","https://openalex.org/W1993009709","https://openalex.org/W1997895626","https://openalex.org/W2017231433","https://openalex.org/W2032794571","https://openalex.org/W2053189341","https://openalex.org/W2083702687","https://openalex.org/W2284268250","https://openalex.org/W2562398824","https://openalex.org/W4210702584"],"related_works":["https://openalex.org/W2562398824","https://openalex.org/W2565990799","https://openalex.org/W2095271866","https://openalex.org/W2127801604","https://openalex.org/W2753324205","https://openalex.org/W1576738253","https://openalex.org/W2589165737","https://openalex.org/W1990562318","https://openalex.org/W3208122300","https://openalex.org/W7024949723"],"abstract_inverted_index":{"Summary":[0],"Brivaracetam":[1],"(":[2,7,22],"BRV":[3,26,63,108,143,195,201],")":[4,9],"and":[5,40,109,144,158,168,202],"levetiracetam":[6],"LEV":[8,29,66,110,148,183,203],"are":[10],"effective":[11],"antiepileptic":[12],"drugs":[13],"that":[14,34,50,69,92,200],"bind":[15,204],"selectively":[16],"to":[17,128,205],"the":[18,55,80,87,99,113,123,129,174,177,189,206],"synaptic":[19,208],"vesicle":[20,209],"2A":[21,57,82,101,131,210],"SV":[23,56,81,100,130],"2A)":[24],"protein.":[25,83],"differs":[27],"from":[28],"in":[30,33,98,122,170,221],"preclinical":[31],"studies":[32],"it":[35],"exhibits":[36],"a":[37,222],"more":[38],"potent":[39],"complete":[41],"seizure":[42],"protection":[43],"across":[44],"animal":[45],"models.":[46],"We":[47],"reported":[48],"previously":[49,121],"an":[51],"allosteric":[52],"modulator":[53,178],"of":[54,79,94,116,126,138,176,191],"protein":[58,102,132,211],"had":[59,133],"differential":[60,105],"effects":[61,106,135],"on":[62,107,136,179,188],"compared":[64],"with":[65,76,185,218],",":[67],"suggesting":[68],"they":[70],"act":[71],"at":[72,212],"different":[73,77,223],"sites":[74,215,220],"or":[75],"conformations":[78],"If":[84],"this":[85],"is":[86],"case,":[88],"then":[89],"we":[90],"hypothesized":[91],"mutations":[93],"specific":[95],"amino":[96,118,162],"acids":[97,119,163],"may":[103],"have":[104],"binding":[111,124,137,184],"by":[112],"modulator.":[114],"Mutation":[115],"some":[117],"identified":[120,165],"site":[125],"racetams":[127],"marked":[134],"both":[139],"[":[140,145,180,192],"3":[141,146,161,181,193],"H]":[142,147,182,194],"(eg,":[149],"W300F,":[150],"F277A,":[151],"G303A,":[152],"F658A,":[153],"Y462A,":[154],"W666A,":[155],"I663A,":[156],"D670A,":[157],"V661A).":[159],"However,":[160],"were":[164],"(K694,":[166],"I273,":[167],"S294)":[169],"which":[171],"mutation":[172],"lost":[173],"effect":[175,187],"no":[186],"modulation":[190],"binding.":[196],"These":[197],"results":[198],"confirm":[199],"human":[207],"closely":[213],"related":[214],"but":[216],"interact":[217],"these":[219],"way.":[224]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4239255504","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-05-12T00:00:00"}
